KOMBITEST CD45 FITC / CD14 PE

KOMBITEST CD45 FITC / CD14 PE
Regulatory status
CE IVD
Format
Conjugate mixture
Reactivity
Human
Application
Variant
50 tests
ED7056
In stock
160.00 USD
Variant
0.1 mg
11-261-C100
In stock
160.00 USD
Product details
Images
Application
Reactivity
Human
Description
The KOMBITEST CD45 FITC / CD14 PE is designed for establishing an optimal lymphocyte gate for immunopheno-typing of erythrocyte-lysed whole blood.
Contents
The reagent contains a premixed combination of mouse monoclonal antibody against human CD45 antigen (clone MEM-28) labeled with fluorescein isothiocyanate (FITC), and mouse monoclonal antibody against human CD14 antigen (clone MEM-15) labeled with R-phycoerythrin (PE). Labeled antibodies are diluted at optimum concentration in stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide. The content of a vial (1 ml) is sufficient for 50 tests.
Formulation
Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Storage and handling
Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
Exbio licence note
The product is intended for In Vitro Diagnostic Use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.
Variant
50 tests
ED7056
In stock
160.00 USD
Variant
0.1 mg
11-261-C100
In stock
160.00 USD